rac-3-Benzyloxy-2-methyl-1-propanol, 97.0%, 250mg

tert-Butyl 2-amino-6-azaspiro[3.4]octane-6-carboxylate, 95.0%, 5g

Fruquintinib, 98%, 25mg

(5-BROMO-2-IODOPHENYL)METHANOL, 95.0%, 10g

(Z)-2-(2-Ethoxyvinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98.0%, 100mg

azacyclotridecane, 95.0%, 5g

(2S,4S)-tert-Butyl 2-cyano-4-fluoropyrrolidine-1-carboxylate, 95.0%, 10g

4-(4-heptyloxyphenyl)-4-oxobutyric acid, 97.0%, 1g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carbaldehyde, 98.00%, 25g

3-[2-(2-Aminoethoxy)ethoxy]propanoic acid 1,1-dimethylethyl ester, 95.0%, 250mg

2-METHYL-3,5-DINITROBENZAMIDE, 95%, 25g

2-Methoxy-3-(trifluoromethyl)aniline, 95.0%, 10g

GC capillary column ROTI®Cap-FFAP, 30 m, 0.32 mm, 0.50 µm, 1 Piece(s)